Pamela Spikner gets 931 Becton Dickinson (NYSE: BDX) shares

Rhea-AI Filing Summary

BECTON DICKINSON & CO senior vice president, controller and chief accounting officer Pamela L. Spikner reported an acquisition of 931 shares of common stock as a grant or award at a price of $0.00 per share. Following this transaction, her directly held stake is 3,323 common shares.

A footnote explains that her direct holdings reflect adjustments tied to the combination of the company’s Biosciences and Diagnostic Solutions businesses with Waters Corp., affecting the number of shares underlying previously reported, unvested time-vested restricted stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Spikner Pamela L.

Role SVP Controller & CAO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	931	$0.00	--

Holdings After Transaction: Common Stock — 3,323 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spikner Pamela L.

(Last) (First) (Middle)

C/O BECTON, DICKINSON AND COMPANY

1 BECTON DRIVE

(Street)

FRANKLIN LAKES NJ 07417

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP Controller & CAO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		931	A	$0	3,323(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Remarks:

	Donna Kalazdy, by power of attorney from Pamela L. Spikner	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BDX executive Pamela Spikner report?

Pamela L. Spikner reported acquiring 931 shares of Becton Dickinson common stock. The shares were received as a grant or award at $0.00 per share, reflecting compensation rather than an open-market purchase and increasing her directly held ownership stake.

How many BDX shares does Pamela Spikner own after this Form 4?

After the reported transaction, Pamela L. Spikner directly owns 3,323 Becton Dickinson common shares. This figure includes the newly acquired 931-share grant and reflects adjustments tied to her previously reported, unvested time-vested restricted stock units as described in the filing footnote.

Was Pamela Spikner’s BDX share acquisition a market purchase?

No, the 931 Becton Dickinson shares were acquired as a grant or award, not bought in the market. The transaction code “A” identifies it as a grant, award, or other acquisition, with a reported price of $0.00 per share in the Form 4 filing.

What does the Waters Corp. adjustment in the BDX Form 4 mean?

The footnote explains that Spikner’s direct holdings reflect adjustments related to combining Becton Dickinson’s Biosciences and Diagnostic Solutions businesses with Waters Corp. This affected the number of shares underlying previously reported, unvested time-vested restricted stock units attributed to her in the ownership figures.

Does Pamela Spikner hold BDX shares directly or indirectly?

The Form 4 indicates that Pamela L. Spikner holds the reported Becton Dickinson shares directly. The ownership code is listed as “D” for direct ownership, and there is no separate entity or trust identified as holding the 3,323 common shares on her behalf.